Facebook Twitter YouTube  
Contact Us
Montefiore News Releases
Home > Newsroom > Montefiore News Releases
Print

Newsroom

Montefiore News Releases

News Releases
Investigators from Montefiore and Einstein to Present Data at American Academy of Dermatology Annual Meeting

NEW YORK (March 20, 2014) – Researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present findings from studies exploring  the treatment and diagnosis of various dermatologic conditions including skin cancer, psoriasis and wound healing at the 72nd  Annual Meeting of the American Academy of Dermatology March 21 – March 25 in Denver. 

“The wide breadth of data and clinical case studies we will present on dermatology conditions both common and rare underscores our commitment to research on the cutting edge of clinical care,” said Steven R. Cohen, M.D., chief, Division of Dermatology, Montefiore and Einstein, and professor of Dermatology, Einstein. “With nearly thirty symposia, poster and oral presentations, Montefiore and Einstein faculty, physicians and residents look forward to engaging in robust scientific exchange with the international dermatology community.” 

Selected research to be presented by Montefiore/Einstein investigators include: 

  • ·Closing a gap in clinical knowledge: Analysis of cases of self-treatment of moles and skin cancer with escharotic and nonescharotic agents in the Internet age – Outcomes analysis of home mole removal and skin cancer treatment using topical agents purchased on the Internet. Poster # 8027, Non-Melanoma Skin Cancer 
     
  • Evaluation of curcumin nanoparticles as a potential therapeutic for wounds – Study of curcumin, a bioactive compound with antimicrobial and anti-inflammatory properties found in turmeric, delivered as a topical wound healing agent in a composite hydrogel/glass nanoparticle platform. Poster # 8332, Basic Science
     
  • Dermatologic Manifestations of New Oncology Drugs – Presentation by Beth McLellan, M.D., on dermatologic adverse events of new anti-cancer drugs including hand-foot skin reaction, hair and nail changes. Sunday, March 23, 2:30 PM, Mile High Ballroom 3B  

Investigators for each of these studies as well as other Montefiore/Einstein faculty who are attending the meeting are available to speak with media.